Alnylam Pharmaceuticals
ALNY
#1118
Rank
โ‚น1.976 T
Marketcap
โ‚น14,758
Share price
-2.00%
Change (1 day)
-63.21%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company